Home › NDC Lookup › Drug shortages › Dextrose Monohydrate 10% Injection

Dextrose Monohydrate 10% Injection shortage

Dextrose Monohydrate 10% Injection is currently listed in shortage by the FDA. The FDA lists 13 affected products. The reported reason: Discontinuation of the manufacture of the drug. This page was last refreshed from FDA data on Oct 4, 2026.

Current ⚠ Supply risk: Low Endocrinology/Metabolism, Gastroenterolo... 13 products 4 manufacturers 1,678 days · 4.6 yr First posted Mar 1, 2022 Updated Oct 1, 2026
Here’s the bottom line

Dextrose Monohydrate 10% Injection has been on the shortage list for over a year, with at least one maker stopping production. All four reporting manufacturers still list some supply available, and Becton Dickinson also lists the 100 mg/mL strength without reporting a shortage.

Don’t stop or change your therapy on your own — ask your pharmacist about other manufacturers (see options) and your prescriber about a long-term plan.

Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →
13
Affected NDCs
4
Reporting manufacturers
4/4
Reporting mfrs supplying
3/3
Affected strengths supplied
8%
NDCs unavailable
1,678
Days in shortage
1,429
Medicaid Rx (2026)
Source: FDA Drug Shortages Database API (openFDA). Last refreshed Oct 4, 2026 · today

What’s in shortage — at a glance

These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Dextrose Monohydrate 10% Injection. Other makers that haven’t reported a problem are shown in the green card below.

Availability of affected NDCs
From the FDA shortage report
13 NDCs
Available 12 Unavailable 1
Affected strengths still supplied
Among manufacturers reporting this shortage
3/3 strengths
Sourceable 3
FDA-reporting manufacturers with supply
Among manufacturers reporting this shortage
4/4 makers
With supply 4
✓ Other manufacturers not reporting a shortage
Still-marketed Dextrose Monohydrate 10% Injection from companies that have not filed an FDA shortage — these are not counted in the figures above. Stock can still vary by pharmacy.
Becton Dickinson and Company
See all other options & details →
Shortage timeline
  1. Oct 1, 2026
    Currently in shortage
    13 of 13 products affected.
  2. Sep 22, 2026
    FDA refreshed this shortage record
    3 products updated.
  3. Sep 17, 2026
    FDA refreshed this shortage record
    3 products updated.
  4. Sep 15, 2026
    FDA refreshed this shortage record
    3 products updated.
  5. Mar 1, 2022
    First reported to the FDA
    13 products first listed.

Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.

What exactly is on backorder — by manufacturer

Manufacturer: B. Braun Medical Inc. 📞 800-227-2862 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) NDC 00264-7520-00 — Available — —
Current Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) NDC 00264-7520-10 — Available — —
Current Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) NDC 00264-7520-20 — Available — —
Manufacturer: Baxter Healthcare 📞 888-229-0001 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02) NDC 00338-0023-02 — Available — —
Current Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03) NDC 00338-0023-03 — Available — —
Current Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04) NDC 00338-0023-04 — Available — —
Manufacturer: Fresenius Kabi USA, LLC 📞 888-386-1300 3 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75) NDC 63323-0824-75 — Available Check wholesalers for inventory —
Current Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74) NDC 63323-0824-74 — Available Check wholesalers for inventory —
Current Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76) NDC 63323-0824-76 — Available Check wholesalers for inventory —
Manufacturer: Otsuka ICU Medical LLC 📞 1-866-829-9025 or [email protected] 4 NDCS click to expand
Status NDC / product Strength Availability Related information Reason
Current Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19) NDC 00990-7938-19 — Unavailable Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. Discontinuation of the manufacture of the drug
Current Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02) NDC 00990-7930-02 — Available This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. —
Current Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09) NDC 00990-7930-09 — Available This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. —
Current Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03) NDC 00990-7930-03 — Available This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical. —

These rows are manufacturer reports to the FDA for Dextrose Monohydrate 10% Injection — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Dextrose Monohydrate 10% Injection? options further down this page.

Why is Dextrose Monohydrate 10% Injection in shortage?

This shortage listing is here because one specific package of Dextrose 10% Injection — the 10 g/100 mL size made by Otsuka ICU Medical LLC and distributed by ICU Medical — has been permanently discontinued. That particular product (NDC 0990-7938-19) is no longer being manufactured and is listed as unavailable.

The good news is that other package sizes and versions of Dextrose 10% from this same report are still listed as available, including other 10 g/100 mL presentations from Otsuka/ICU Medical, as well as products from B. Braun, Fresenius Kabi, and Baxter. Fresenius Kabi's note does suggest checking with wholesalers for their inventory. So this is really about one specific discontinued package, not the entire product going away.

FDA reason code(s): Discontinuation of the manufacture of the drug

Based on the manufacturer-reported reason(s) and notes on file with the FDA for Dextrose Monohydrate 10% Injection, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.

What should I do if I take Dextrose Monohydrate 10% Injection?

Dextrose Monohydrate 10% Injection is currently on the FDA shortage list, but the overall supply picture is steady. Every strength has at least one manufacturer reporting available product, so the medicine you take should still be obtainable.

All three listed strengths — 10 g/100 mL, 100 mg/1 mL, and 100 g/1000 mL — have an available source right now. None of the strengths is completely without supply. One thing to note: a single product code in the 10 g/100 mL strength (distributed by ICU Medical) has been discontinued, but other makers still list that same strength as available. The FDA reason recorded here is discontinuation by a manufacturer. Even so, four of four manufacturers on this record are reporting supply, which is why the risk level is low.

Here is what I suggest:

  • Do not stop, skip, or change your doses on your own.
  • Ask your pharmacy to order your strength; they can check wholesalers and other manufacturers, including suppliers like B. Braun, Fresenius Kabi, Otsuka ICU Medical, and Baxter.
  • The same medicine is also available from Becton Dickinson; your pharmacy may be able to source it, though it may not be in local stock.
  • If your exact product cannot be found, ask your prescriber or pharmacist about options.

Manufacturer contact numbers are listed on this page for reference. This is general national information and may not match your local pharmacy's stock.

See “Where else can I get Dextrose Monohydrate 10% Injection?” below ↓ The same medicine from manufacturers not reporting a shortage, alternative dosage forms, and therapeutic equivalents with pricing.
If you are a patient:
  • Don’t stop or change the medication on your own — talk to your prescriber first.
  • If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
  • Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
  • Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Keep reading
Our full Dextrose guide

Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.

Read the Dextrose guide →

Where else can I get Dextrose Monohydrate 10% Injection?

FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Dextrose Monohydrate 10% Injection is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.

Same medicine, other manufacturers (not reported short)

Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:

ProductStrengthForm / routeManufacturerNDC
Dextrose DEXTROSE MONOHYDRATE 100 mg/mL Injection, Solution · Intravenous Becton Dickinson and Company 17271-0721-05
Therapeutic equivalents & pricing 3 productsclick to expand

Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.

ProductManufacturerPackageNADAC $/unitAB ratingAvailability
Dextrose 10 g/100mLNDC 00264-7520-00 B. 1000 ml — AP FDA listed
Dextrose 10 g/100mLNDC 00264-7520-10 B. 500 ml — AP FDA listed
Dextrose 10 g/100mLNDC 00264-7520-20 B. 250 ml — AP FDA listed

Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.

Other drugs in the same treatment class

These are different medicines — not other versions of Dextrose Monohydrate 10% Injection — that fall in the same broad treatment class (iv solutions: dextrose-water) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.

Identity & classification

GCN Seq No 063861
GCN 99573
HICL code 000918
Ingredient (HICL) Dextrose 10 % In Water
HIC1 code C
Therapeutic class — broad (HIC1) Electrolyte Balance/Metabolism/Nutrition
HIC2 code C5
Therapeutic class — intermediate (HIC2) Carbohydrates And/Or Proteins
HIC3 code C5J
Therapeutic class — specific (HIC3) Iv Solutions: Dextrose-Water
AHFS code 40:20.00.00
AHFS class Caloric Agents
FDB label name DEXTROSE 10%-WATER IV SOLUTION
FDB brand name Dextrose In Water
Legend status F — Federal legend — prescription drug or device
GPI-1480100020002020
GPI classDextrose
Where does this data come from?
Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.

Other endocrinology/metabolism, gastroenterology, other, pediatric shortages

Dextrose Monohydrate 10% Injection shortage FAQs

Is Dextrose Monohydrate 10% Injection in shortage?
Yes — the FDA currently lists Dextrose Monohydrate 10% Injection in shortage (status: “Current”, first reported Mar 1, 2022). 13 of 13 products are affected. This is national, manufacturer-reported data, so your pharmacy may still have stock.
Why is Dextrose Monohydrate 10% Injection in shortage?
The manufacturer-reported reason on file with the FDA: Discontinuation of the manufacture of the drug.
Which products are affected?
Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00) (NDC 00264-7520-00); Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10) (NDC 00264-7520-10); Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20) (NDC 00264-7520-20). The full per-NDC list (availability, manufacturer and status) is in the table above — each NDC links to its own page.
When will Dextrose Monohydrate 10% Injection be available again?
The FDA does not publish a guaranteed restock date, and no estimated-recovery note is on file. Availability can change daily — confirm with your pharmacy.
Can I still get Dextrose Monohydrate 10% somewhere?
Other manufacturers (Becton Dickinson and Company) still market it and have not reported a shortage. See “Where else can I get Dextrose Monohydrate 10% Injection?” above — stock still varies by pharmacy.
What should I do if I take Dextrose Monohydrate 10% Injection?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another manufacturer or a different strength/package size, and ask your prescriber about a long-term plan before your supply runs out.

Still have a question about the Dextrose Monohydrate 10% Injection shortage?

Ask a pharmacist about this shortage →
How to read the Supply-Risk rating
Low (1–2)Multiple manufacturers still supplying and most strengths or pack sizes sourceable.
Medium (3)Some constraint — fewer suppliers or a notable share of NDCs unavailable.
High (4–5)Down to a single source, most strengths or pack sizes unsourceable, or a long-running outage.
Where does this data come from?
Shortage records come from the FDA Drug Shortages Database API via openFDA (/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.
Data structure & sourcing designed and verified by Dr. Brian Staiger, PharmD.
← Back to all current drug shortages